PFE251017P00019000 Option on Pfizer Inc

PFE Stock  USD 24.39  0.40  1.61%   
PFE251017P00019000 is a PUT option contract on Pfizer's common stock with a strick price of 19.0 expiring on 2025-10-17. The contract was not traded in recent days and, as of today, has 43 days remaining before the expiration. The option is currently trading at an ask price of $0.04. The implied volatility as of the 4th of September is 43.0.
When exercised, put options on Pfizer produce a short position in Pfizer Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Pfizer's downside price movement.

Rule 16 of 2025-10-17 Option Contract

The options market is anticipating that Pfizer Inc will have an average daily up or down price movement of about 0.0% per day over the life of the option. With Pfizer trading at USD 24.39, that is roughly USD 0.0. If you think that the market is fully understating Pfizer's daily price movement you should consider buying Pfizer Inc options at that current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Out Of The Money Put Option on Pfizer

An 'Out of The Money' option on Pfizer has a strike price that Pfizer Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Pfizer's 'Out of The Money' options include buying the options if you expect a big move in Pfizer's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Put Contract NamePFE251017P00019000
Expires On2025-10-17
Days Before Expriration43
Open Interest64
Strike Price19.0
Last Traded At0.06
Current Price Spread0.0 | 0.04

Pfizer long PUT Option Payoff at expiration

Put options written on Pfizer grant holders of the option the right to sell a specified amount of Pfizer at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Pfizer Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Pfizer is like buying insurance aginst Pfizer's downside shift.
   Profit   
       Pfizer Price At Expiration  

Pfizer short PUT Option Payoff at expiration

By selling Pfizer's put option, the investors signal their bearish sentiment. A short position in a put option written on Pfizer will generally make money when the underlying price is above the strike price. Therefore Pfizer's put payoff at expiration depends on where the Pfizer Stock price is relative to the put option strike price. The breakeven price of 19.0 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Pfizer's price. Finally, at the strike price of 19.0, the payoff chart is constant and positive.
   Profit   
       Pfizer Price At Expiration  
View All Pfizer Options

Pfizer Inc Available Put Options

Pfizer's option chain is a display of a range of information that helps investors for ways to trade options on Pfizer. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Pfizer. It also shows strike prices and maturity days for a Pfizer against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
 Put
PFE251121P00012000850112.00.0 - 0.020.02Out
 Put
PFE251121P00013000213.00.0 - 0.020.02Out
 Put
PFE251121P000140005414.00.0 - 0.020.01Out
 Put
PFE251121P00015000420415.00.0 - 0.040.01Out
 Put
PFE251121P00016000647916.00.0 - 0.050.03Out
 Put
PFE251121P0001700063217.00.01 - 0.050.03Out
 Put
PFE251121P00018000731018.00.01 - 0.070.05Out
 Put
PFE251121P00019000236719.00.02 - 0.090.07Out
 Put
PFE251121P00020000820120.00.09 - 0.10.09Out
 Put
PFE251121P00021000221221.00.14 - 0.170.17Out
 Put
PFE251121P00022000378222.00.25 - 0.280.29Out
 Put
PFE251121P00023000712823.00.42 - 0.460.44Out
 Put
PFE251121P00024000607324.00.72 - 0.750.79Out
 Put
PFE251121P000250001005925.01.15 - 1.21.19Out
 Put
PFE251121P00026000183926.01.74 - 1.791.89In
 Put
PFE251121P00027000246027.02.42 - 2.522.59In
 Put
PFE251121P0002800018328.03.3 - 3.43.35In
 Put
PFE251121P0002900013529.04.2 - 4.353.45In
 Put
PFE251121P00030000183230.05.2 - 5.34.85In
 Put
PFE251121P000310007231.06.15 - 6.36.2In
 Put
PFE251121P00032000155232.07.15 - 7.257.35In
 Put
PFE251121P0003500016435.010.1 - 10.29.26In
 Put
PFE251121P00037000037.012.1 - 12.2512.3In
 Put
PFE251121P00040000140.014.4 - 15.215.8In
 Put
PFE251121P00042000042.016.4 - 17.217.75In
 Put
PFE251121P00045000045.019.5 - 20.1521.25In

Pfizer Corporate Directors

Helen HobbsIndependent DirectorProfile
Shantanu NarayenLead Independent DirectorProfile
James SmithIndependent DirectorProfile
Susan DesmondHellmannIndependent DirectorProfile
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
69.74
Dividend Share
1.7
Earnings Share
1.89
Revenue Per Share
11.252
Quarterly Revenue Growth
0.103
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.